Cervical cancer drug gets funding

Health minister Sussan Ley has announced the September PBS listing of bevacizumab (Avastin) for the treatment of persistent, recurrent or metastatic cervical cancer.

The drug is subsidised in cases where surgery and radiotherapy are not viable treatments.

“This announcement will help save the lives of over 200 Australian women who aren’t responding to conventional treatments for their